Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that ...
Heightened levels of sensitivity may lead to depression and/or anxiety.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback